Literature DB >> 6873067

Inhibition of NS-protein-stimulated human-platelet adenylate cyclase by epinephrine and stable GTP analogs.

K H Jakobs, G Schultz, B Gaugler, T Pfeuffer.   

Abstract

The influence of purified, preactivated NS protein, mediating adenylate cyclase stimulation by hormones and guanine nucleotides, was studied on adenylate cyclase activity in membranes of human platelets. The preactivated coupling protein caused a large increase in platelet enzyme activity. The activation occurred after a short lag phase and exhibited saturation. NS protein increased the V of the platelet adenylate cyclase without change in the enzyme's affinity for the substrate, MgATP, whereas the apparent affinity for Mg2+ was increased by more than one order of magnitude. The NS-protein-activated human platelet adenylate cyclase was inhibited by the hormone, epinephrine, and by the stable GTP analogs, guanosine 5'-[beta, gamma-imido]triphosphate and guanosine 5'-[gamma-thio]triphosphate. The stable GTP analog or hormone-induced adenylate cyclase inhibition was not competitive with regard to the concentration of NS protein. Inhibition of NS-protein-stimulated platelet adenylate cyclase caused by stable GTP analogs appeared to be persistent, was amplified by epinephrine and was accompanied by a large decrease in the enzyme's apparent affinity for Mg2+. The data suggest that the hormone-sensitive adenylate cyclase is regulated by two guanine-nucleotide-binding sites, NS and Ni, mediating enzyme stimulation and inhibition, respectively, by hormones and guanine nucleotides, and that the two coupling components interact in a non-competitive manner with the adenylate cyclase, exhibiting high and low affinity for Mg2+ when affected by NS and Ni, respectively.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6873067     DOI: 10.1111/j.1432-1033.1983.tb07574.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  6 in total

1.  Inhibition of human platelet adenylate cyclase activity by adrenaline, thrombin and collagen: analysis and reinterpretation of experimental data.

Authors:  A Juska; R W Farndale
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

2.  Activation of adenylate cyclase in human platelet membranes by guanosine 5'-[beta gamma-imido]triphosphate is inhibited by cyclic-AMP-dependent phosphorylation. Slow activation occurs in the absence of ATP.

Authors:  R W Farndale; S K Wong; B R Martin
Journal:  Biochem J       Date:  1987-03-15       Impact factor: 3.857

3.  Dual regulation of adenylate cyclase. A signal transduction mechanism of membrane receptors.

Authors:  K H Jakobs; M Minuth; S Bauer; R Grandt; C Greiner; P Zubin
Journal:  Basic Res Cardiol       Date:  1986 Jan-Feb       Impact factor: 17.165

4.  Evidence for regulation of human platelet adenylate cyclase by phosphorylation. Inhibition by ATP and guanosine 5'-[beta-thio]diphosphate occur by distinct mechanisms.

Authors:  I A Wadman; R W Farndale; B R Martin
Journal:  Biochem J       Date:  1991-06-15       Impact factor: 3.857

5.  Forskolin sensitizes human platelet adenylate cyclase to modulation of substrate (MgATP) affinity by hormones.

Authors:  Y Watanabe; K H Jakobs
Journal:  Biochem J       Date:  1986-07-01       Impact factor: 3.857

6.  The interactions between the activatory guanine nucleotide binding protein and the catalytic subunit of adenylate cyclase in rat liver plasma membranes.

Authors:  S K Wong; B R Martin
Journal:  Biochem J       Date:  1985-10-01       Impact factor: 3.857

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.